Bluebird Historical Balance Sheet

BLUE Stock

USD 1.02 0.07 7.37%

Trend analysis of Bluebird bio balance sheet accounts such as Other Current Liab of 55.2 M, Total Current Liabilities of 105.5 M or Total Stockholder Equity of 214.5 M provides information on Bluebird Bio's total assets, liabilities, and equity, which is the actual value of Bluebird bio to its prevalent stockholders. By breaking down trends over time using Bluebird Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bluebird bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bluebird bio is a good buy for the upcoming year.

Bluebird Bio Inventory

(1.34 Million)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

About Bluebird Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bluebird bio at a specified time, usually calculated after every quarter, six months, or one year. Bluebird Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bluebird Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bluebird currently owns. An asset can also be divided into two categories, current and non-current.

Bluebird Bio Balance Sheet Chart

Bluebird Bio Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Bluebird bio uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, Bluebird Bio's Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Net Debt is expected to grow to about 203.3 M, whereas Total Current Liabilities is forecasted to decline to about 105.5 M.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Bluebird Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bluebird bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bluebird Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bluebird bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Bluebird Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Net Debt is expected to grow to about 203.3 M, whereas Total Current Liabilities is forecasted to decline to about 105.5 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	101.7M	50.5M	58.1M	55.2M
Total Assets	593.8M	554.9M	638.1M	1.1B

Other Current Liab Total Assets

Bluebird Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.7	0.7	0.96	0.7	0.67	0.56	-0.42	-0.27	0.51	0.76	0.86	0.6	0.6	0.94	0.55	0.36	0.93	0.6	0.58	0.54	0.7	0.63	0.94	0.06	0.46
Other Current Liab	0.7		0.95	0.6	0.31	0.75	0.21	0.01	-0.69	0.83	0.35	0.71	0.92	0.92	0.63	0.71	0.67	0.7	0.59	0.87	0.77	0.83	0.74	0.61	0.15	0.6
Total Current Liabilities	0.7	0.95		0.58	0.33	0.86	0.2	0.08	-0.78	0.93	0.35	0.77	0.98	0.98	0.58	0.86	0.79	0.66	0.69	0.82	0.86	0.92	0.85	0.58	0.39	0.75
Total Stockholder Equity	0.96	0.6	0.58		0.79	0.47	0.67	-0.6	-0.07	0.38	0.82	0.78	0.47	0.47	0.99	0.45	0.22	0.95	0.47	0.54	0.34	0.57	0.42	0.98	-0.15	0.25
Other Liab	0.7	0.31	0.33	0.79		0.2	0.62	-0.5	0.23	0.15	0.53	0.62	0.22	0.22	0.73	0.18	-0.11	0.81	0.22	0.49	-0.01	0.3	0.15	0.72	-0.14	-0.03
Property Plant And Equipment Net	0.67	0.75	0.86	0.47	0.2		0.03	0.29	-0.79	0.81	0.27	0.76	0.87	0.87	0.45	0.79	0.78	0.52	0.87	0.55	0.91	0.94	1.0	0.46	0.64	0.86
Current Deferred Revenue	0.56	0.21	0.2	0.67	0.62	0.03		-0.78	0.27	0.03	0.78	0.28	0.02	0.03	0.71	0.12	-0.2	0.56	-0.06	0.16	-0.08	0.07	-0.01	0.69	-0.44	-0.05
Net Debt	-0.42	0.01	0.08	-0.6	-0.5	0.29	-0.78		-0.53	0.24	-0.83	0.0	0.24	0.24	-0.63	0.14	0.41	-0.44	0.25	-0.07	0.36	0.18	0.33	-0.67	0.64	0.37
Retained Earnings	-0.27	-0.69	-0.78	-0.07	0.23	-0.79	0.27	-0.53		-0.79	0.06	-0.48	-0.83	-0.83	-0.07	-0.84	-0.91	-0.12	-0.59	-0.48	-0.94	-0.74	-0.82	-0.06	-0.68	-0.91
Accounts Payable	0.51	0.83	0.93	0.38	0.15	0.81	0.03	0.24	-0.79		0.19	0.66	0.95	0.95	0.38	0.81	0.82	0.47	0.7	0.67	0.82	0.88	0.81	0.38	0.48	0.73
Cash	0.76	0.35	0.35	0.82	0.53	0.27	0.78	-0.83	0.06	0.19		0.39	0.21	0.21	0.84	0.33	0.07	0.64	0.24	0.27	0.18	0.32	0.24	0.89	-0.22	0.17
Non Current Assets Total	0.86	0.71	0.77	0.78	0.62	0.76	0.28	0.0	-0.48	0.66	0.39		0.74	0.74	0.74	0.7	0.6	0.84	0.73	0.58	0.68	0.82	0.74	0.69	0.33	0.61
Non Currrent Assets Other	0.6	0.92	0.98	0.47	0.22	0.87	0.02	0.24	-0.83	0.95	0.21	0.74		1.0	0.46	0.85	0.86	0.57	0.76	0.79	0.87	0.94	0.87	0.46	0.46	0.76
Other Assets	0.6	0.92	0.98	0.47	0.22	0.87	0.03	0.24	-0.83	0.95	0.21	0.74	1.0		0.46	0.85	0.86	0.57	0.75	0.79	0.88	0.94	0.87	0.46	0.46	0.76
Cash And Short Term Investments	0.94	0.63	0.58	0.99	0.73	0.45	0.71	-0.63	-0.07	0.38	0.84	0.74	0.46	0.46		0.41	0.21	0.94	0.46	0.53	0.33	0.56	0.41	0.99	-0.23	0.21
Common Stock Total Equity	0.55	0.71	0.86	0.45	0.18	0.79	0.12	0.14	-0.84	0.81	0.33	0.7	0.85	0.85	0.41		0.91	0.42	0.64	0.56	0.88	0.81	0.8	0.42	0.59	0.89
Common Stock Shares Outstanding	0.36	0.67	0.79	0.22	-0.11	0.78	-0.2	0.41	-0.91	0.82	0.07	0.6	0.86	0.86	0.21	0.91		0.25	0.74	0.45	0.9	0.83	0.81	0.2	0.63	0.85
Short Term Investments	0.93	0.7	0.66	0.95	0.81	0.52	0.56	-0.44	-0.12	0.47	0.64	0.84	0.57	0.57	0.94	0.42	0.25		0.53	0.68	0.37	0.65	0.48	0.92	-0.12	0.22
Non Current Liabilities Total	0.6	0.59	0.69	0.47	0.22	0.87	-0.06	0.25	-0.59	0.7	0.24	0.73	0.76	0.75	0.46	0.64	0.74	0.53		0.39	0.71	0.92	0.86	0.46	0.49	0.61
Other Current Assets	0.58	0.87	0.82	0.54	0.49	0.55	0.16	-0.07	-0.48	0.67	0.27	0.58	0.79	0.79	0.53	0.56	0.45	0.68	0.39		0.54	0.65	0.52	0.54	0.13	0.39
Other Stockholder Equity	0.54	0.77	0.86	0.34	-0.01	0.91	-0.08	0.36	-0.94	0.82	0.18	0.68	0.87	0.88	0.33	0.88	0.9	0.37	0.71	0.54		0.85	0.93	0.33	0.66	0.95
Total Liab	0.7	0.83	0.92	0.57	0.3	0.94	0.07	0.18	-0.74	0.88	0.32	0.82	0.94	0.94	0.56	0.81	0.83	0.65	0.92	0.65	0.85		0.93	0.56	0.48	0.74
Property Plant And Equipment Gross	0.63	0.74	0.85	0.42	0.15	1.0	-0.01	0.33	-0.82	0.81	0.24	0.74	0.87	0.87	0.41	0.8	0.81	0.48	0.86	0.52	0.93	0.93		0.42	0.67	0.88
Total Current Assets	0.94	0.61	0.58	0.98	0.72	0.46	0.69	-0.67	-0.06	0.38	0.89	0.69	0.46	0.46	0.99	0.42	0.2	0.92	0.46	0.54	0.33	0.56	0.42		-0.19	0.23
Short Term Debt	0.06	0.15	0.39	-0.15	-0.14	0.64	-0.44	0.64	-0.68	0.48	-0.22	0.33	0.46	0.46	-0.23	0.59	0.63	-0.12	0.49	0.13	0.66	0.48	0.67	-0.19		0.78
Common Stock	0.46	0.6	0.75	0.25	-0.03	0.86	-0.05	0.37	-0.91	0.73	0.17	0.61	0.76	0.76	0.21	0.89	0.85	0.22	0.61	0.39	0.95	0.74	0.88	0.23	0.78

Click cells to compare fundamentals

Bluebird Bio Account Relationship Matchups

Bluebird Bio balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	1.8B	593.8M	554.9M	638.1M	1.1B
Other Current Liab	141.6M	145.4M	101.7M	50.5M	58.1M	55.2M
Total Current Liabilities	223.6M	203.6M	153.0M	128.2M	147.5M	105.5M
Total Stockholder Equity	1.3B	1.4B	374.3M	196.3M	225.8M	214.5M
Other Liab	58.0M	48.0M	54.6M	93K	107.0K	101.6K
Property Plant And Equipment Net	337.1M	346.9M	101.2M	291.4M	335.1M	351.8M
Current Deferred Revenue	18.9M	11.6M	2.3M	1.5M	1.4M	1.3M
Net Debt	(136.2M)	(124.7M)	(71.6M)	168.4M	193.6M	203.3M
Retained Earnings	(2.3B)	(2.9B)	(3.7B)	(4.0B)	(3.6B)	(3.4B)
Accounts Payable	43.0M	21.6M	25.9M	25.1M	28.9M	16.3M
Cash	327.2M	317.7M	161.2M	113.0M	130.0M	123.5M
Non Current Assets Total	575.3M	565.7M	257.3M	355.4M	408.7M	350.9M
Non Currrent Assets Other	79.2M	72.8M	53.3M	52.1M	59.9M	33.0M
Other Assets	79.2M	72.8M	53.3M	52.1M	59.9M	33.2M
Cash And Short Term Investments	1.2B	1.3B	396.6M	181.7M	209.0M	198.6M
Common Stock Total Equity	547K	554K	665K	711K	817.7K	431.4K
Common Stock Shares Outstanding	55.2M	62.2M	68.9M	78.6M	90.4M	47.4M
Short Term Investments	779.2M	833.5M	138.3M	67.3M	77.4M	73.5M
Liabilities And Stockholders Equity	1.7B	1.8B	593.8M	554.9M	638.1M	1.1B
Non Current Liabilities Total	218.9M	222.6M	66.5M	230.3M	264.9M	154.1M
Other Current Assets	45.7M	64.3M	37.0M	8.4M	9.6M	9.1M
Other Stockholder Equity	3.6B	4.3B	4.1B	4.2B	4.8B	5.1B
Total Liab	442.4M	426.2M	219.5M	358.6M	412.3M	259.6M
Property Plant And Equipment Gross	337.1M	346.9M	121.6M	313.3M	360.3M	378.3M
Total Current Assets	1.2B	1.2B	336.5M	199.5M	229.4M	217.9M
Accumulated Other Comprehensive Income	(1.9M)	(5.5M)	(2.9M)	(4.1M)	(3.7M)	(3.8M)
Short Term Debt	20.2M	25.0M	23.2M	51.2M	58.8M	61.8M
Common Stock	554K	665K	711K	830K	954.5K	1.0M
Property Plant Equipment	151.2M	162.8M	101.2M	291.4M	335.1M	351.8M
Net Tangible Assets	1.3B	1.3B	368.6M	185.8M	213.7M	203.0M
Net Receivables	12.8M	26.8M	11.4M	10.8M	12.4M	11.0M
Retained Earnings Total Equity	(1.5B)	(2.3B)	(2.9B)	(3.7B)	(3.3B)	(3.2B)
Capital Surpluse	3.4B	3.6B	4.3B	4.1B	4.7B	2.6B
Inventory	(144.3M)	(149.7M)	(108.5M)	(1.4M)	(1.3M)	(1.3M)
Non Current Liabilities Other	218.9M	222.6M	93K	92K	105.8K	100.5K
Intangible Assets	14.3M	10.0M	5.6M	4.9M	4.4M	4.2M
Long Term Investments	131.5M	122.9M	97.1M	1.4M	1.3M	1.2M

Pair Trading with Bluebird Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluebird Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Bluebird Stock

0.49

LPTX

Leap Therapeutics Financial Report 20th of May 2024

Pair Corr

The ability to find closely correlated positions to Bluebird Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluebird Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluebird Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluebird bio to buy it.

The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluebird Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluebird bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bluebird Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:

How To Invest In Bluebird

Details

Is Bluebird Stock a good investment?

Details

What is Bluebird Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing

Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.63)

Revenue Per Share

0.214

Quarterly Revenue Growth

173.535

Return On Assets

(0.15)

Return On Equity

(0.48)

The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bluebird Historical Balance Sheet

Bluebird Bio Inventory

(1.34 Million)

About Bluebird Balance Sheet Analysis

Bluebird Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Bluebird Bio balance sheet Correlations

Bluebird Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bluebird Bio balance sheet Accounts

Pair Trading with Bluebird Bio

Moving against Bluebird Stock

Complementary Tools for Bluebird Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 1.0	Non Currrent Assets Other
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments
Non Currrent Assets Other	+ 0.98	Total Current Liabilities
Other Assets	+ 0.98	Total Current Liabilities

Other Stockholder Equity	- 0.94	Retained Earnings
Common Stock	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.91	Retained Earnings
Common Stock Total Equity	- 0.84	Retained Earnings
Other Assets	- 0.83	Retained Earnings
Non Currrent Assets Other	- 0.83	Retained Earnings